Author

Charles Farthing

Observed names: And Charles Farthing, C F Farthing, C Farthing, C. F. FARTHING, C. F. Farthing, C. FARTHING, C. Farthing, C.F. FARTHING, C.F. Farthing, CHARLES FARTHING, Charles F Farthing, Charles F. Farthing, F Charles Farthing, Farthing, Charles F.

Observed institutions: University of Southern California, Merck & Co., Inc., Rahway, NJ, USA (United States), AIDS Healthcare Foundation, Riyadh Armed Forces Hospital, Aaron Diamond AIDS Research Center, University of California, Los Angeles, University of Massachusetts Chan Medical School, Raigmore Hospital, Charing Cross Hospital, NYU Langone Health, St Vincent's Hospital Sydney, AIDS Research Consortium of Atlanta, Bellevue Hospital Center, Orlando Immunology Center, Gilead Sciences (United States), Albany Medical College, New York University, University of Cincinnati Medical Center

OpenAlex ID: A5111843008

Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome

1994 · R A Koup, J T Safrit, et al. · Journal of Virology · 2,495

PDF

Efficacy and safety of darunavir-ritonavir at week 48 in treatment-experienced patients with HIV-1 infection in POWER 1 and 2: a pooled subgroup analysis of data from two randomised trials

2007 · Bonaventura Clotet, Nicholas Bellos, et al. · The Lancet · 485

Antiviral Activity, Pharmacokinetics, and Dose Response of the HIV-1 Integrase Inhibitor GS-9137 (JTK-303) in Treatment-Naive and Treatment-Experienced Patients

2006 · Edwin DeJesus, Daniel Berger, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 269

Prevalence of Antibody to Human T-lymphotropic Virus Type Iii in Aids and Aids-risk Patients in Britain

1984 · R Cheingsong-Popov, R.A Weiss, et al. · The Lancet · 229

A randomized trial assessing the impact of phenotypic resistance testing on antiretroviral therapy

2002 · Calvin J. Cohen, Susan Hunt, et al. · AIDS · 196

Ritonavir and saquinavir combination therapy for the treatment of HIV infection

1999 · William Cameron, Anthony J. Japour, et al. · AIDS · 191

Idiopathic CD4+ T-Lymphocytopenia -- Immunodeficiency without Evidence of HIV Infection

1993 · David D. Ho, Yunzhen Cao, et al. · New England Journal of Medicine · 151

PDF

Treatment of resistant aphthous ulceration with thalidomide in patients positive for HIV antibody.

1989 · M. Youle, J. Clarbour, et al. · BMJ · 138

PDF

Skin disease in homosexual patients with Acquired Immune Deficiency Syndrome (AIDS) and lesser forms of human T cell Leukaemia Virus (HTLV III) disease

1985 · C.F. FARTHING, R.C.D. STAUGHTON, et al. · Clinical and Experimental Dermatology · 113

The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex

1993 · David A. Cooper, P. Olov Pehrson, et al. · AIDS · 85

Early Virologic Failure in a Pilot Study Evaluating the Efficacy of Therapy Containing Once-Daily Abacavir, Lamivudine, and Tenofovir DF in Treatment-Naive HIV-Infected Patients

2005 · Homayoun Khanlou, Vivian Yeh, et al. · AIDS Patient Care and STDs · 77

Efficacy of the Protease Inhibitors Tipranavir plus Ritonavir in Treatment-Experienced Patients: 24-Week Analysis from the RESIST-1 Trial

2006 · J. Gathe, D. A. Cooper, et al. · Clinical Infectious Diseases · 76

Impact of an Educational Program on Efficacy and Adherence With a Twice-Daily Lamivudine/Zidovudine/Abacavir Regimen in Underrepresented HIV-Infected Patients

2003 · M. Keith Rawlings, Melanie A. Thompson, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 72

Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS

2001 · Jeffrey M. Jacobson, Richard Hafner, et al. · AIDS · 65

Once-Daily versus Twice-Daily Lamivudine, in Combination with Zidovudine and Efavirenz, for the Treatment of Antiretroviral-Naive Adults with HIV Infection: A Randomized Equivalence Trial

2004 · E. DeJesus, D. McCarty, et al. · Clinical Infectious Diseases · 59

Efficacy of an Individualized Adherence Support Program with Contingent Reinforcement Among Nonadherent HIV-Positive Patients

2006 · Marjan Javanbakht, Paul Prosser, et al. · Journal of the International Association of Physicians in AIDS Care · 52

Pilot Study of Topical Trifluridine for the Treatment of Acyclovir-Resistant Mucocutaneous Herpes Simplex Disease in Patients with AIDS (ACTG 172)

1996 · H. A. Kessler, S. Hurwitz, et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 49

Response to

2006 · Homayoun Khanlou, Stan Louie, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 45

Clinical Findings and Serological Evidence of Htlv-iii Infection in Homosexual Contacts of Patients With Aids and Persistent Generalised Lymphadenopathy in London

1984 · B.G. Gazzard, C. Farthing, et al. · The Lancet · 37

Papuloerythroderma--a further case with the 'deck chair sign'.

1986 · C F Farthing, R C Staughton, et al. · PubMed · 34

Treatment of cytomegalovirus pneumonitis with foscarnet (trisodium phosphonoformate) in patients with AIDS

1987 · C. Farthing, M. G. Anderson, et al. · Journal of Medical Virology · 33

Phosphonoformate (foscarnet): a pilot study in AIDS and AIDS related complex.

1987 · C F Farthing, A G Dalgleish, et al. · PubMed · 33

An exploratory study of long-term neurocognitive outcomes following recovery from opportunistic brain infections in HIV+ adults

2008 · Andrew J. Levine, Charles H. Hinkin, et al. · Journal of Clinical and Experimental Neuropsychology · 29

Increased CD4+ T‐Lymphocyte Senescence Fraction in Advanced Human Immunodeficiency Virus Type 1 Infection

1999 · W. S. NICHOLS, S. SCHNEIDER, et al. · Scandinavian Journal of Immunology · 29

PDF

The efficacy and safety of zidovudine with or without acyclovir in the treatment of patients with AIDS-related complex

1991 · David A. Cooper, Court Pedersen, et al. · AIDS · 29

Works count: 72

Citation count: 5,412

H-index: 27

I10-index: 37